1、序号:1
题名:Pharmacodynamicsand pharmacokinetics of the HMG-CoA reductaseinhibitors.Similarities and differences
作者:H. Lennernas,G. Fager.
期刊: Clin.Pharmacokinet,
页码:1997, 32:403-425.
链接:无
2、序号:2
题名:HPLC Determinationof Lovastatin in Rat Tissue
作者:Z.F.Zhang,Z.Y.Yang.
期刊:Chromatography2007, 66(7-8)
页码:487-491.
链接:无
3、序号:3
题名:Expandedclinical evaluation of lovastain(EXCEL)study results:efficacy in modifying plasma lipoproteins and adverse event profile in8245 patients with moderate hypercholesterolemia
作者:R.H.Bradford, C.L. Shear, A.N. Chremos et al.
期刊: Arch.Intern.Med.,1991, 151
页码:43-49.
链接:无
4、序号:4
题名:Mevinolin:a highly potent competitive inhibitor ofhydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
作者:A.W.Alberts,J. Chen, G. Kuron.
期刊:Proceedingsof the National Academy of Sciences of the United States of America, 1980, 77(7)
页码:3957-3961.
链接:无